Bentham Science Logo

Current Neuropharmacology

Volume 17, 12 Issues, 2019
ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)
This journal supports open access

Ranking and Category

  • 59th of 267 in


  • 33rd of 267 in

    Pharmacology & Pharmacy

Order Your Article Before Print

Meet the Executive Guest Editor(s)

A. Alfaro-Rodriguez
Ins tuto Nacional de Rehabilitacin
Mexico City
The research carried out by Dr. Alfonso Alfaro-Rodríguez has focused in the study of the chemistry of the brain. His studies are centered in the search for neuronal damage mechanisms caused by neurodegenerative diseases like Parkinson's, brain injuries, and currently nociception. He has also dabbled in the study of several antiepileptic and antidepressant drugs over the central nervous system. The role of monoamines like serotonin and acetylcholine along with several catecholamines at neuronal and molecular level in the development of neurodegenerative diseases has been a central topic of his research. The research over the mechanisms of brain damage by means of different neurotoxic pathways unchained by neurodegenerative diseases has led him to successfully explore the role of neuroprotective drugs in a myriad of animal models. With his research he has allowed the assessment of neuronal damage and the disabilities caused by these diseases. At present he has centered in the development of novel research protocols over the mechanisms of pain and the elaboration of diagnostic strategies for the timely diagnostic of it; by means of the employment of new drugs that could improve quality of life of patients suffering of chronic pain.

S.M. Nabavi
Baqiyatallah University of Medical Sciences
Seyed Mohammad Nabavi is a biotechnologist and senior scientist of Applied Biotechnology Research Center, Baqiyatallah University of Medical Science and a member of Iran's National Elites Foundation. His research focuses on the molecular pharmacology of natural products. He is author/co-author of 250 publications in international journals, 51 communications at national and international congress, and six chapters in book series. Seyed Mohammad Nabavi has been selected as a group of scientists recognized as Highly Cited Researchers by Clarivate Analytics, 2018.


F. Nicoletti
University Rome"da Sapienza"

View Full Editorial Board

Journal History

Current Neuropharmacology was introduced in 2003 with the assistance of Dr. T.E. Salt, who is the current Editor-in-Chief serving since 2003.
Track Your Manuscript:

Scopus CiteScore Metrics: 3.95

New eBook

Neurobiology of Mood Disorders

You can view the contents of this eBook [here] or purchase it [here].

Related Journals

Related eBooks

eBooks Catalog